Global Microbial Alternative Protein Market Growth 2025-2031

September 2025 | 88 pages | ID: G5838356E420EN
LP Information

Abstracts

The global Microbial Alternative Protein market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Microbial alternative protein refers to the use of microorganisms (usually proteins produced by microbial fermentation) as food ingredients that replace traditional animal and plant proteins. This method typically involves placing microorganisms, such as bacteria, yeast, or fungi, in a specific culture medium to produce proteins through a fermentation process.

United States market for Microbial Alternative Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Microbial Alternative Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Microbial Alternative Protein is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Microbial Alternative Protein players cover AgriProtein (South Africa), Ynsect (France), Enterra Feed Corporation (Canada), Protix (The Netherlands), Proti-Farm Holding NV (The Netherlands), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Microbial Alternative Protein Industry Forecast” looks at past sales and reviews total world Microbial Alternative Protein sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbial Alternative Protein sales for 2025 through 2031. With Microbial Alternative Protein sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbial Alternative Protein industry.

This Insight Report provides a comprehensive analysis of the global Microbial Alternative Protein landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microbial Alternative Protein portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbial Alternative Protein market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbial Alternative Protein and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbial Alternative Protein.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbial Alternative Protein market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Yeast Protein
• Microalgae Protein
• Bacterial Protein
• Other

Segmentation by Application:

• Food
• Feed
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• AgriProtein (South Africa)
• Ynsect (France)
• Enterra Feed Corporation (Canada)
• Protix (The Netherlands)
• Proti-Farm Holding NV (The Netherlands)
• Entomo Farms (Canada)
• Global Bugs Asia Co., Ltd. (Thailand)
• Aspire Food Group (U.S.)
• Tiny Farms (U.S.)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Microbial Alternative Protein market?
What factors are driving Microbial Alternative Protein market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microbial Alternative Protein market opportunities vary by end market size?
How does Microbial Alternative Protein break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microbial Alternative Protein Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Microbial Alternative Protein by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Microbial Alternative Protein by Country/Region, 2020, 2024 & 2031
2.2 Microbial Alternative Protein Segment by Type
  2.2.1 Yeast Protein
  2.2.2 Microalgae Protein
  2.2.3 Bacterial Protein
  2.2.4 Other
2.3 Microbial Alternative Protein Sales by Type
  2.3.1 Global Microbial Alternative Protein Sales Market Share by Type (2020-2025)
  2.3.2 Global Microbial Alternative Protein Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Microbial Alternative Protein Sale Price by Type (2020-2025)
2.4 Microbial Alternative Protein Segment by Application
  2.4.1 Food
  2.4.2 Feed
  2.4.3 Others
2.5 Microbial Alternative Protein Sales by Application
  2.5.1 Global Microbial Alternative Protein Sale Market Share by Application (2020-2025)
  2.5.2 Global Microbial Alternative Protein Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Microbial Alternative Protein Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Microbial Alternative Protein Breakdown Data by Company
  3.1.1 Global Microbial Alternative Protein Annual Sales by Company (2020-2025)
  3.1.2 Global Microbial Alternative Protein Sales Market Share by Company (2020-2025)
3.2 Global Microbial Alternative Protein Annual Revenue by Company (2020-2025)
  3.2.1 Global Microbial Alternative Protein Revenue by Company (2020-2025)
  3.2.2 Global Microbial Alternative Protein Revenue Market Share by Company (2020-2025)
3.3 Global Microbial Alternative Protein Sale Price by Company
3.4 Key Manufacturers Microbial Alternative Protein Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Microbial Alternative Protein Product Location Distribution
  3.4.2 Players Microbial Alternative Protein Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR MICROBIAL ALTERNATIVE PROTEIN BY GEOGRAPHIC REGION

4.1 World Historic Microbial Alternative Protein Market Size by Geographic Region (2020-2025)
  4.1.1 Global Microbial Alternative Protein Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Microbial Alternative Protein Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Microbial Alternative Protein Market Size by Country/Region (2020-2025)
  4.2.1 Global Microbial Alternative Protein Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Microbial Alternative Protein Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microbial Alternative Protein Sales Growth
4.4 APAC Microbial Alternative Protein Sales Growth
4.5 Europe Microbial Alternative Protein Sales Growth
4.6 Middle East & Africa Microbial Alternative Protein Sales Growth

5 AMERICAS

5.1 Americas Microbial Alternative Protein Sales by Country
  5.1.1 Americas Microbial Alternative Protein Sales by Country (2020-2025)
  5.1.2 Americas Microbial Alternative Protein Revenue by Country (2020-2025)
5.2 Americas Microbial Alternative Protein Sales by Type (2020-2025)
5.3 Americas Microbial Alternative Protein Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microbial Alternative Protein Sales by Region
  6.1.1 APAC Microbial Alternative Protein Sales by Region (2020-2025)
  6.1.2 APAC Microbial Alternative Protein Revenue by Region (2020-2025)
6.2 APAC Microbial Alternative Protein Sales by Type (2020-2025)
6.3 APAC Microbial Alternative Protein Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Microbial Alternative Protein by Country
  7.1.1 Europe Microbial Alternative Protein Sales by Country (2020-2025)
  7.1.2 Europe Microbial Alternative Protein Revenue by Country (2020-2025)
7.2 Europe Microbial Alternative Protein Sales by Type (2020-2025)
7.3 Europe Microbial Alternative Protein Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microbial Alternative Protein by Country
  8.1.1 Middle East & Africa Microbial Alternative Protein Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Microbial Alternative Protein Revenue by Country (2020-2025)
8.2 Middle East & Africa Microbial Alternative Protein Sales by Type (2020-2025)
8.3 Middle East & Africa Microbial Alternative Protein Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Microbial Alternative Protein
10.3 Manufacturing Process Analysis of Microbial Alternative Protein
10.4 Industry Chain Structure of Microbial Alternative Protein

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Microbial Alternative Protein Distributors
11.3 Microbial Alternative Protein Customer

12 WORLD FORECAST REVIEW FOR MICROBIAL ALTERNATIVE PROTEIN BY GEOGRAPHIC REGION

12.1 Global Microbial Alternative Protein Market Size Forecast by Region
  12.1.1 Global Microbial Alternative Protein Forecast by Region (2026-2031)
  12.1.2 Global Microbial Alternative Protein Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Microbial Alternative Protein Forecast by Type (2026-2031)
12.7 Global Microbial Alternative Protein Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 AgriProtein (South Africa)
  13.1.1 AgriProtein (South Africa) Company Information
  13.1.2 AgriProtein (South Africa) Microbial Alternative Protein Product Portfolios and Specifications
  13.1.3 AgriProtein (South Africa) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 AgriProtein (South Africa) Main Business Overview
  13.1.5 AgriProtein (South Africa) Latest Developments
13.2 Ynsect (France)
  13.2.1 Ynsect (France) Company Information
  13.2.2 Ynsect (France) Microbial Alternative Protein Product Portfolios and Specifications
  13.2.3 Ynsect (France) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Ynsect (France) Main Business Overview
  13.2.5 Ynsect (France) Latest Developments
13.3 Enterra Feed Corporation (Canada)
  13.3.1 Enterra Feed Corporation (Canada) Company Information
  13.3.2 Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolios and Specifications
  13.3.3 Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Enterra Feed Corporation (Canada) Main Business Overview
  13.3.5 Enterra Feed Corporation (Canada) Latest Developments
13.4 Protix (The Netherlands)
  13.4.1 Protix (The Netherlands) Company Information
  13.4.2 Protix (The Netherlands) Microbial Alternative Protein Product Portfolios and Specifications
  13.4.3 Protix (The Netherlands) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Protix (The Netherlands) Main Business Overview
  13.4.5 Protix (The Netherlands) Latest Developments
13.5 Proti-Farm Holding NV (The Netherlands)
  13.5.1 Proti-Farm Holding NV (The Netherlands) Company Information
  13.5.2 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolios and Specifications
  13.5.3 Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Proti-Farm Holding NV (The Netherlands) Main Business Overview
  13.5.5 Proti-Farm Holding NV (The Netherlands) Latest Developments
13.6 Entomo Farms (Canada)
  13.6.1 Entomo Farms (Canada) Company Information
  13.6.2 Entomo Farms (Canada) Microbial Alternative Protein Product Portfolios and Specifications
  13.6.3 Entomo Farms (Canada) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Entomo Farms (Canada) Main Business Overview
  13.6.5 Entomo Farms (Canada) Latest Developments
13.7 Global Bugs Asia Co., Ltd. (Thailand)
  13.7.1 Global Bugs Asia Co., Ltd. (Thailand) Company Information
  13.7.2 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolios and Specifications
  13.7.3 Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Global Bugs Asia Co., Ltd. (Thailand) Main Business Overview
  13.7.5 Global Bugs Asia Co., Ltd. (Thailand) Latest Developments
13.8 Aspire Food Group (U.S.)
  13.8.1 Aspire Food Group (U.S.) Company Information
  13.8.2 Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolios and Specifications
  13.8.3 Aspire Food Group (U.S.) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Aspire Food Group (U.S.) Main Business Overview
  13.8.5 Aspire Food Group (U.S.) Latest Developments
13.9 Tiny Farms (U.S.)
  13.9.1 Tiny Farms (U.S.) Company Information
  13.9.2 Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolios and Specifications
  13.9.3 Tiny Farms (U.S.) Microbial Alternative Protein Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Tiny Farms (U.S.) Main Business Overview
  13.9.5 Tiny Farms (U.S.) Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Microbial Alternative Protein Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Microbial Alternative Protein Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Yeast Protein
Table 4. Major Players of Microalgae Protein
Table 5. Major Players of Bacterial Protein
Table 6. Major Players of Other
Table 7. Global Microbial Alternative Protein Sales by Type (2020-2025) & (Kiloton)
Table 8. Global Microbial Alternative Protein Sales Market Share by Type (2020-2025)
Table 9. Global Microbial Alternative Protein Revenue by Type (2020-2025) & ($ million)
Table 10. Global Microbial Alternative Protein Revenue Market Share by Type (2020-2025)
Table 11. Global Microbial Alternative Protein Sale Price by Type (2020-2025) & (US$/Ton)
Table 12. Global Microbial Alternative Protein Sale by Application (2020-2025) & (Kiloton)
Table 13. Global Microbial Alternative Protein Sale Market Share by Application (2020-2025)
Table 14. Global Microbial Alternative Protein Revenue by Application (2020-2025) & ($ million)
Table 15. Global Microbial Alternative Protein Revenue Market Share by Application (2020-2025)
Table 16. Global Microbial Alternative Protein Sale Price by Application (2020-2025) & (US$/Ton)
Table 17. Global Microbial Alternative Protein Sales by Company (2020-2025) & (Kiloton)
Table 18. Global Microbial Alternative Protein Sales Market Share by Company (2020-2025)
Table 19. Global Microbial Alternative Protein Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Microbial Alternative Protein Revenue Market Share by Company (2020-2025)
Table 21. Global Microbial Alternative Protein Sale Price by Company (2020-2025) & (US$/Ton)
Table 22. Key Manufacturers Microbial Alternative Protein Producing Area Distribution and Sales Area
Table 23. Players Microbial Alternative Protein Products Offered
Table 24. Microbial Alternative Protein Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Microbial Alternative Protein Sales by Geographic Region (2020-2025) & (Kiloton)
Table 28. Global Microbial Alternative Protein Sales Market Share Geographic Region (2020-2025)
Table 29. Global Microbial Alternative Protein Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Microbial Alternative Protein Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Microbial Alternative Protein Sales by Country/Region (2020-2025) & (Kiloton)
Table 32. Global Microbial Alternative Protein Sales Market Share by Country/Region (2020-2025)
Table 33. Global Microbial Alternative Protein Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Microbial Alternative Protein Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Microbial Alternative Protein Sales by Country (2020-2025) & (Kiloton)
Table 36. Americas Microbial Alternative Protein Sales Market Share by Country (2020-2025)
Table 37. Americas Microbial Alternative Protein Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Microbial Alternative Protein Sales by Type (2020-2025) & (Kiloton)
Table 39. Americas Microbial Alternative Protein Sales by Application (2020-2025) & (Kiloton)
Table 40. APAC Microbial Alternative Protein Sales by Region (2020-2025) & (Kiloton)
Table 41. APAC Microbial Alternative Protein Sales Market Share by Region (2020-2025)
Table 42. APAC Microbial Alternative Protein Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Microbial Alternative Protein Sales by Type (2020-2025) & (Kiloton)
Table 44. APAC Microbial Alternative Protein Sales by Application (2020-2025) & (Kiloton)
Table 45. Europe Microbial Alternative Protein Sales by Country (2020-2025) & (Kiloton)
Table 46. Europe Microbial Alternative Protein Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Microbial Alternative Protein Sales by Type (2020-2025) & (Kiloton)
Table 48. Europe Microbial Alternative Protein Sales by Application (2020-2025) & (Kiloton)
Table 49. Middle East & Africa Microbial Alternative Protein Sales by Country (2020-2025) & (Kiloton)
Table 50. Middle East & Africa Microbial Alternative Protein Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Microbial Alternative Protein Sales by Type (2020-2025) & (Kiloton)
Table 52. Middle East & Africa Microbial Alternative Protein Sales by Application (2020-2025) & (Kiloton)
Table 53. Key Market Drivers & Growth Opportunities of Microbial Alternative Protein
Table 54. Key Market Challenges & Risks of Microbial Alternative Protein
Table 55. Key Industry Trends of Microbial Alternative Protein
Table 56. Microbial Alternative Protein Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Microbial Alternative Protein Distributors List
Table 59. Microbial Alternative Protein Customer List
Table 60. Global Microbial Alternative Protein Sales Forecast by Region (2026-2031) & (Kiloton)
Table 61. Global Microbial Alternative Protein Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Microbial Alternative Protein Sales Forecast by Country (2026-2031) & (Kiloton)
Table 63. Americas Microbial Alternative Protein Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Microbial Alternative Protein Sales Forecast by Region (2026-2031) & (Kiloton)
Table 65. APAC Microbial Alternative Protein Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Microbial Alternative Protein Sales Forecast by Country (2026-2031) & (Kiloton)
Table 67. Europe Microbial Alternative Protein Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Microbial Alternative Protein Sales Forecast by Country (2026-2031) & (Kiloton)
Table 69. Middle East & Africa Microbial Alternative Protein Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Microbial Alternative Protein Sales Forecast by Type (2026-2031) & (Kiloton)
Table 71. Global Microbial Alternative Protein Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Microbial Alternative Protein Sales Forecast by Application (2026-2031) & (Kiloton)
Table 73. Global Microbial Alternative Protein Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. AgriProtein (South Africa) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 75. AgriProtein (South Africa) Microbial Alternative Protein Product Portfolios and Specifications
Table 76. AgriProtein (South Africa) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 77. AgriProtein (South Africa) Main Business
Table 78. AgriProtein (South Africa) Latest Developments
Table 79. Ynsect (France) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 80. Ynsect (France) Microbial Alternative Protein Product Portfolios and Specifications
Table 81. Ynsect (France) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 82. Ynsect (France) Main Business
Table 83. Ynsect (France) Latest Developments
Table 84. Enterra Feed Corporation (Canada) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 85. Enterra Feed Corporation (Canada) Microbial Alternative Protein Product Portfolios and Specifications
Table 86. Enterra Feed Corporation (Canada) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 87. Enterra Feed Corporation (Canada) Main Business
Table 88. Enterra Feed Corporation (Canada) Latest Developments
Table 89. Protix (The Netherlands) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 90. Protix (The Netherlands) Microbial Alternative Protein Product Portfolios and Specifications
Table 91. Protix (The Netherlands) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 92. Protix (The Netherlands) Main Business
Table 93. Protix (The Netherlands) Latest Developments
Table 94. Proti-Farm Holding NV (The Netherlands) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 95. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Product Portfolios and Specifications
Table 96. Proti-Farm Holding NV (The Netherlands) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 97. Proti-Farm Holding NV (The Netherlands) Main Business
Table 98. Proti-Farm Holding NV (The Netherlands) Latest Developments
Table 99. Entomo Farms (Canada) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 100. Entomo Farms (Canada) Microbial Alternative Protein Product Portfolios and Specifications
Table 101. Entomo Farms (Canada) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Entomo Farms (Canada) Main Business
Table 103. Entomo Farms (Canada) Latest Developments
Table 104. Global Bugs Asia Co., Ltd. (Thailand) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 105. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Product Portfolios and Specifications
Table 106. Global Bugs Asia Co., Ltd. (Thailand) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Global Bugs Asia Co., Ltd. (Thailand) Main Business
Table 108. Global Bugs Asia Co., Ltd. (Thailand) Latest Developments
Table 109. Aspire Food Group (U.S.) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 110. Aspire Food Group (U.S.) Microbial Alternative Protein Product Portfolios and Specifications
Table 111. Aspire Food Group (U.S.) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 112. Aspire Food Group (U.S.) Main Business
Table 113. Aspire Food Group (U.S.) Latest Developments
Table 114. Tiny Farms (U.S.) Basic Information, Microbial Alternative Protein Manufacturing Base, Sales Area and Its Competitors
Table 115. Tiny Farms (U.S.) Microbial Alternative Protein Product Portfolios and Specifications
Table 116. Tiny Farms (U.S.) Microbial Alternative Protein Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 117. Tiny Farms (U.S.) Main Business
Table 118. Tiny Farms (U.S.) Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Microbial Alternative Protein
Figure 2. Microbial Alternative Protein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Microbial Alternative Protein Sales Growth Rate 2020-2031 (Kiloton)
Figure 7. Global Microbial Alternative Protein Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Microbial Alternative Protein Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Microbial Alternative Protein Sales Market Share by Country/Region (2024)
Figure 10. Microbial Alternative Protein Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Yeast Protein
Figure 12. Product Picture of Microalgae Protein
Figure 13. Product Picture of Bacterial Protein
Figure 14. Product Picture of Other
Figure 15. Global Microbial Alternative Protein Sales Market Share by Type in 2025
Figure 16. Global Microbial Alternative Protein Revenue Market Share by Type (2020-2025)
Figure 17. Microbial Alternative Protein Consumed in Food
Figure 18. Global Microbial Alternative Protein Market: Food (2020-2025) & (Kiloton)
Figure 19. Microbial Alternative Protein Consumed in Feed
Figure 20. Global Microbial Alternative Protein Market: Feed (2020-2025) & (Kiloton)
Figure 21. Microbial Alternative Protein Consumed in Others
Figure 22. Global Microbial Alternative Protein Market: Others (2020-2025) & (Kiloton)
Figure 23. Global Microbial Alternative Protein Sale Market Share by Application (2024)
Figure 24. Global Microbial Alternative Protein Revenue Market Share by Application in 2025
Figure 25. Microbial Alternative Protein Sales by Company in 2025 (Kiloton)
Figure 26. Global Microbial Alternative Protein Sales Market Share by Company in 2025
Figure 27. Microbial Alternative Protein Revenue by Company in 2025 ($ millions)
Figure 28. Global Microbial Alternative Protein Revenue Market Share by Company in 2025
Figure 29. Global Microbial Alternative Protein Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Microbial Alternative Protein Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Microbial Alternative Protein Sales 2020-2025 (Kiloton)
Figure 32. Americas Microbial Alternative Protein Revenue 2020-2025 ($ millions)
Figure 33. APAC Microbial Alternative Protein Sales 2020-2025 (Kiloton)
Figure 34. APAC Microbial Alternative Protein Revenue 2020-2025 ($ millions)
Figure 35. Europe Microbial Alternative Protein Sales 2020-2025 (Kiloton)
Figure 36. Europe Microbial Alternative Protein Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Microbial Alternative Protein Sales 2020-2025 (Kiloton)
Figure 38. Middle East & Africa Microbial Alternative Protein Revenue 2020-2025 ($ millions)
Figure 39. Americas Microbial Alternative Protein Sales Market Share by Country in 2025
Figure 40. Americas Microbial Alternative Protein Revenue Market Share by Country (2020-2025)
Figure 41. Americas Microbial Alternative Protein Sales Market Share by Type (2020-2025)
Figure 42. Americas Microbial Alternative Protein Sales Market Share by Application (2020-2025)
Figure 43. United States Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Microbial Alternative Protein Sales Market Share by Region in 2025
Figure 48. APAC Microbial Alternative Protein Revenue Market Share by Region (2020-2025)
Figure 49. APAC Microbial Alternative Protein Sales Market Share by Type (2020-2025)
Figure 50. APAC Microbial Alternative Protein Sales Market Share by Application (2020-2025)
Figure 51. China Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 55. India Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Microbial Alternative Protein Sales Market Share by Country in 2025
Figure 59. Europe Microbial Alternative Protein Revenue Market Share by Country (2020-2025)
Figure 60. Europe Microbial Alternative Protein Sales Market Share by Type (2020-2025)
Figure 61. Europe Microbial Alternative Protein Sales Market Share by Application (2020-2025)
Figure 62. Germany Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 63. France Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Microbial Alternative Protein Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Microbial Alternative Protein Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Microbial Alternative Protein Sales Market Share by Application (2020-2025)
Figure 70. Egypt Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Microbial Alternative Protein Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Microbial Alternative Protein in 2025
Figure 76. Manufacturing Process Analysis of Microbial Alternative Protein
Figure 77. Industry Chain Structure of Microbial Alternative Protein
Figure 78. Channels of Distribution
Figure 79. Global Microbial Alternative Protein Sales Market Forecast by Region (2026-2031)
Figure 80. Global Microbial Alternative Protein Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Microbial Alternative Protein Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Microbial Alternative Protein Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Microbial Alternative Protein Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Microbial Alternative Protein Revenue Market Share Forecast by Application (2026-2031)